Investors Menu

David Pernock

David Pernock, Executive Vice President, Operations

David has been our President and Chief Commercial Officer since January 2017. David brings a wealth of pharmaceutical and biotechnology experience to the Eagle leadership team, having previously served as a member of the board from April 2015 through December 2016. David’s strategic focus and entrepreneurial spirit has contributed to the commercial success of many products throughout his distinguished career.

Before joining Eagle, David served as Chairman of the board of directors and CEO (2010-2017) of Fibrocell Science, Inc., a publicly traded autologous cell and gene therapy company.

David previously held various positions at GlaxoSmithKline, most notably serving as Senior Vice President of the Pharmaceuticals, Vaccines (Biologics), Oncology, Acute Care, and HIV Divisions. He also served as President of Reliant Pharmaceuticals and as a director of Martek Biosciences Corporation.

David holds a BS in business administration from Arizona State University.

Investor Contact

Communications, Inc.
Lisa M. Wilson,

For all other media inquiries, please contact us.